CAS RN: 94-59-7


A) Monitor fluids and electrolytes if significant vomiting occurs.
B) Both kidney and liver function should be monitored following a significant sassafras oil ingestion that contains safrole.
C) Serum or plasma levels of safrole or its metabolites are not readily available or clinically useful.
Find more information on this substance at: PubChem, PubMed